Edition:
United Kingdom

Caladrius Biosciences Inc (CLBS.OQ)

CLBS.OQ on NASDAQ Stock Exchange Capital Market

4.88USD
13 Nov 2018
Change (% chg)

$-0.25 (-4.87%)
Prev Close
$5.13
Open
$5.23
Day's High
$5.28
Day's Low
$4.64
Volume
7,197
Avg. Vol
8,223
52-wk High
$11.65
52-wk Low
$2.92

Select another date:

Mon, Oct 22 2018

BRIEF-Roche Says Phase III Study On Alecensa Meets Primary Endpoint

* SAYS WILL TO ANNOUNCE RESULTS FROM THE PHASE III ALESIA STUDY, SHOWING THAT ALECENSA® (ALECTINIB) MET ITS PRIMARY ENDPOINT OF INVESTIGATOR-ASSESSED (INV) PROGRESSION-FREE SURVIVAL (PFS)

Select another date: